Form 13-F position report

SANA BIOTECHNOLOGY INC COM

Reported by Capital World Investors

SANA CUSIP 799566104 Manager CIK 0001422849

First reported at 1,531,307 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q2 2023
Shares 1,531,307 Quarter-end amount reported
Reported value $9,126,590 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-06-30 9126590
2023-09-30 5926158
2023-12-31 6247733
2024-03-31 54490350
2024-06-30 29751731
2024-09-30 22667986
2024-12-31 8881927
2025-03-31 9154379
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for SANA BIOTECHNOLOGY INC COM held by Capital World Investors.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -5,449,035 (-100.0%) 0 $0 2025-08-13
Q1 2025 Unchanged 5,449,035 0 (0.0%) < 0.01% $9,154,379 2025-05-12
Q4 2024 Unchanged 5,449,035 0 (0.0%) < 0.01% $8,881,927 2025-02-13
Q3 2024 Unchanged 5,449,035 0 (0.0%) < 0.01% $22,667,986 2024-11-13
Q2 2024 Unchanged 5,449,035 0 (0.0%) < 0.01% $29,751,731 2024-08-13
Q1 2024 Added 5,449,035 +3,917,728 (255.8%) < 0.01% $54,490,350 2024-05-14
Q4 2023 Unchanged 1,531,307 0 (0.0%) < 0.01% $6,247,733 2024-02-13
Q3 2023 Unchanged 1,531,307 0 (0.0%) < 0.01% $5,926,158 2023-11-13
Q2 2023 New 1,531,307 +1,531,307 (0.0%) < 0.01% $9,126,590 2023-08-11

Who else reported the position

134 managers reported SANA BIOTECHNOLOGY INC COM for Q2 2023.

Managers reporting SANA BIOTECHNOLOGY INC COM in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Flagship Pioneering Inc Reduced 33,290,018 -949,000 8.85% $198,408,507 10 qtrs
FMR LLC Added 16,644,065 +7,489,972 < 0.01% $99,198,628 10 qtrs
BAILLIE GIFFORD & CO Reduced 10,836,161 -40,768 0.05% $64,583,520 10 qtrs
CANADA PENSION PLAN INVESTMENT BOARD Unchanged 10,175,000 0 0.09% $60,643,000 10 qtrs
VANGUARD GROUP INC Reduced 9,060,418 -25,514 < 0.01% $54,000,092 10 qtrs
BlackRock Inc Added 7,884,777 +82,950 < 0.01% $46,993,272 10 qtrs
Public Sector Pension Investment Board Reduced 5,371,293 -1,028,707 0.22% $32,012,906 10 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 5,123,428 +612,642 < 0.01% $30,536,000 10 qtrs
STATE STREET CORPORATION Reduced 4,837,803 -855,577 < 0.01% $28,833,306 10 qtrs
Crestline Management LP Added 3,365,624 +154,687 2.09% $20,059,119 9 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 11, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,531,307
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.